What Is Cancer?
RAD51C is an inclusion eligibility criterion in six clinical trials for non-modest cell lung carcinoma, of which five are open and 1 is closed. Of the trials that include RAD51C status and non-compact cell lung carcinoma as inclusion criteria, 1 is phase 1 , two are phase 1/phase 2 ,...